Doctors in Tel Aviv teamed up with a photojournalist to learn more about the role of the unsung heroes who place their patientcompanion at the heart of their world. This article was first published in [more]
Shared decision making is ethically sound and the evidence shows it leads to better outcomes. But if a patient is determined that they want no part in the decision, is it paternalistic to insist? This [more]
As we learn more about what lies behind the differences in cancer outcomes across Europe, the question becomes: how do we end them? This article was first published in The Oncologist vol.18 no.12, and is [more]
Two practitioners of integrative oncology make the case for using non-traditional therapies alongside mainstream care and for abandoning the term complementary and alternative medicine as unhelpful and misleading in this comprehensive article, which [more]
Online communities can help patients learn about and weigh up the options open to them. Where enough patients are involved, they are also helping to shape those options, opening up new opportunities for accelerating research [more]
People take treatment decisions on the basis of their personal perspectives as much as the medical pros and cons. Doctors need to be able to deal with this. This article was first published in The [more]
This Focus article presents a debate between two experts to try to understand more about why younger women with breast cancer tend to have a poorer prognosis than their older counterparts. Breast cancer in young [more]
Do you ever let the death of a patient get to you? In this Focus piece, one cancer surgeon talks about his own experience and argues that shutting down your emotional responses is neither feasible [more]
Smartphones give patients the technology not only to record a consultation but also to share it privately, post it on a social network or even upload it to a public website. What does this mean [more]
In oncology, the contribution of the human touch which alternative medical treatments offer, and the placebo effect they induce, can be easy to overlook. Download full article
Hopes that angiogenesis inhibition could improve outcomes when used adjuvantly in colorectal cancer received a setback at the end of April, with the announcement that the NSABP C-08 trial had failed to meet its primary [more]
Chemobrain’ is an informal term coined by patients who are or were on chemotherapy, to express the feeling of being not quite switched on or able to think clearly and focus on the [more]
Cancer may be caused by stem cells gone bad. If that proves to be correct, it should revolutionise treatment. Download full article